
Monday, November 17, 2008
Vinci Capital investit l'argent des retraites dans les entreprises prometteuses
Download : 24H 17 nov 08
Tuesday, September 23, 2008
Vinci Capital a investi 6 millions de francs dans la technologie développée par Omnisens
Download : Omnisens Le Temps 230908
Saturday, August 30, 2008
Tatis:parcours du combattant sur les grands marchés publics
Download : Tatis - PME June 08
Tuesday, August 05, 2008
Sensimed se déploie en suivant la voie de la moindre résistance
Download : Sensimed - Agefi article
Friday, July 11, 2008
immatics appoints Paul G. Higham as Chief Executive Officer
Download : 9July2008
Monday, June 16, 2008
Sensimed receives scientific and business recognition
Download : Sensimed 16 June 08
Monday, May 05, 2008
Immatics launches Phase I/II study of IMA910 cancer vaccine in colorectal cancer
Download : IMA910
Tuesday, February 12, 2008
Private-Equity: a good moment for pension funds
Download : PME-Magazine 02.08
Thursday, April 03, 2008
Sensimed nominated in the Red Herring top 100 tech startups in europe in 2008
Monday, February 25, 2008
Kuros - Tests regarding severe burns
Monday, February 25, 2008
Dartfish experience in College
Download : Dartfish - EPS Brochure Jan/Feb 08
Wednesday, January 23, 2008
Datamars-20 years of innovation
Download : Datamars-press communication 23.1.08
Tuesday, January 15, 2008
Sensimed - lentille pour mieux prévenir et traiter le glaucome
Download : Sensimed - lentille pour mieux prévenir et traiter le glaucome
Monday, December 10, 2007
Addex and Merck&Co., Inc - developement of medicaments for Parkinson desease
Download : Parkinson _3.12.2007 (FR)
Monday, December 10, 2007
L'AGEFI: Recognition of Dartfish SA innovation
Download : L'AGEFI - Dartfish SA _ 4.12.2007
Monday, December 03, 2007
immatics is laureate in the "2007 STEP Award"
Download : immatics 2007 STEP Award
Monday, November 26, 2007
Le Temps: Renaissance PME and Vinci Capital announce the launch of their 3rd generation fund - Renaissance Technologies 3.
Download : Le Temps Lancement RT3 novembre 2007 (FR)
Monday, October 01, 2007
immatics launches Phase 2 study on cancer vaccine IMA901
Download : immatics - Phase 2 study on cancer vaccine
Wednesday, June 06, 2007
FierceBiotech names immatics biotechnologies one of the “Fierce 15” biotech companies of 2007
Download : FierceBiotech
Thursday, May 24, 2007
Precimed Japan and Fujiflex announce partnership
Download : Japan Fujiflex partnership
Wednesday, May 16, 2007
AGEFI:Investors are looking for experienced team
Download : Experienced team
Thursday, April 26, 2007
Precimed devient boursocompatible
Download : Precimed devient boursocompatible
Thursday, February 22, 2007
Allergan Announces Its Acquisition of EndoArt
Download : Acquisition of EndoArt
Thursday, February 08, 2007
immatics receives €40 million in second round of funding / Largest private biotech financing round in Germany since 2001
Download : Immatics receives €40 million
Sunday, January 07, 2007
Precimed, du medtech pour devenir un vrai acteur global.
Download : Precimed, acteur global
Friday, December 15, 2006
Swiss Banking Yearbook 2006. Olivier Tavel and Christian Waldvogel, Vinci Capital: The private equity is back!
Download : The private equity is back!
Monday, November 06, 2006
Datamars SA Completes CHF 11 million Growth Capital Round November 10 2006
Download : Datamars SA Growth Capital
Thursday, October 12, 2006
Swisscom has commissioned Vinci Capital to invest in Swiss technology firms with a high growth potential
Download : Swisscom goes for innovation
Tuesday, September 19, 2006
Addex Pharmaceuticals Raises CHF40 million
Download : Addex Raises CHF40 million
Wednesday, August 30, 2006
Addex Pharmaceuticals commences Phase II clinical trials programme with ADX10059
Thursday, August 24, 2006
Pour les entreprises non cotées, la maîtrise prime sur le capital
Download : Entreprises non cotées, la maîtrise prime sur le capital
Saturday, July 15, 2006
Silverwire: un cas d'école à Genève
Download : Silverwire: un cas d'école à Genève
Monday, April 10, 2006
Endoart SA Completes US$ 10.5 million (CHF 13.5 million) Venture Financing Round
Download : Endoart SA completes Venture Financing Round
Sunday, February 26, 2006
Silverwire tisse sa toile dans la photo numérique et vise une entrée en Bourse
Download : Silverwire vise une entrée en Bourse
Sunday, January 15, 2006
Le casse-tête du capital-risque. Bien peu de gens font ce que nous faisons ensemble: rechercher des fonds, investir dans des entreprises helvétiques et les suivre pas à pas
Thursday, November 17, 2005
Silverwire primé dans la catégorie "Jeune Industrie"
Download : Silverwire primé
Thursday, November 17, 2005
Silverwire, acteur de la photo numérique, primé à Genève
Download : Silverwire primé à Genève
Thursday, September 22, 2005
Addex Pharmaceuticals Initiates Phase I Trials with ADX10059, a novel compound intended for Anxiety and Migraine
Download : Addex Pharmaceuticals Phase I Trials
Wednesday, September 14, 2005
Precimed Group secures CHF 34 Million Equity Investment
Wednesday, September 07, 2005
Ethische Dimensionen bei einer Firmenübernahme
Download : Firmenübernahme
Monday, August 15, 2005
Olivier Tavel et Christian Waldvogel - La renaissance des créateurs d'emploi.
Download : La renaissance des créateurs d'emploi
Friday, July 29, 2005
Sword avale le lausannois Linkvest. Le capital-risqueur Vinci Capital récolte le double de sa mise
Download : Sword avale Linkvest
Tuesday, April 19, 2005
Renforcé, Vinci Capital joue un rôle majeur pour créer les emplois de demain
Wednesday, February 23, 2005
Capital-risque: Carrière/Expérience
Download : Capital-risque: Carrière/Expérience
Saturday, January 22, 2005
La société suisse Team Brendel rachetée par SuperOffice
Download : Team Brendel racheté par SuperOffice
Monday, January 17, 2005
Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease
Download : Collaboration within Addex Pharmaceutical and Ortho-McNeil
Vinci Capital - PSE-C - CH-1015 Lausanne - Tel +41 (0)21 693 92 34 - info@vincicapital.ch
Vinci Capital
PSE Bâtiment C
CH-1015 Lausanne
Tel +41 (0)21 693 92 34